Source	Human embryonic kidney cell, HEK293-derived human BPIFB1 protein Thr22-Gln484, with a C-terminal 6-His tag
Purity	>95%, by SDS-PAGE visualized with Silver Staining and quantitative densitometry by Coomassie® Blue Staining.
Endotoxin level	<0.10 EU per 1 μg of the protein by the LAL method.
N-terminal sequence Analysis	Thr22
Predicted Molecular Mass	51 kDa
SDS-PAGE	55-61 kDa, under reducing conditions
Activity	Measured by its ability to bind fluorescein-conjugated E. coli Bioparticles. The ED₅₀ for this effect is 30-240 ng/mL.

Recombinant Human BPIFB1 His-tag Protein, CF Scientific Data Examples

	Recombinant Human BPIFB1 His-tag Protein Binding Activity Recombinant Human BPIFB1 His-tag binds to fluorescein-conjugatedE. coliBioparticles. The ED₅₀ for this effect is 30-240 ng/mL.
	Recombinant Human BPIFB1 His-tag Protein SDS-PAGE 2 μg/lane of Recombinant Human BPIFB1 His-tag was resolved with SDS-PAGE under reducing (R) and non-reducing (NR) conditions and visualized by Coomassie® blue staining, showing bands at 55-61 kDa.

Formulation, Preparation and Storage

Carrier Free

What does CF mean?

CF stands for Carrier Free (CF). We typically add Bovine Serum Albumin (BSA) as a carrier protein to our recombinant proteins. Adding a carrier protein enhances protein stability, increases shelf-life, and allows the recombinant protein to be stored at a more dilute concentration. The carrier free version does not contain BSA.

What formulation is right for me?

In general, we advise purchasing the recombinant protein with BSA for use in cell or tissue culture, or as an ELISA standard. In contrast, the carrier free protein is recommended for applications, in which the presence of BSA could interfere.

10195-BF

Formulation	Lyophilized from a 0.2 μm filtered solution in PBS.
Reconstitution	Reconstitute at 500 μg/mL in PBS.
Shipping	The product is shipped at ambient temperature. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage:	Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20 to -70 °C as supplied. 1 month, 2 to 8 °C under sterile conditions after reconstitution. 3 months, -20 to -70 °C under sterile conditions after reconstitution.

Reconstitution Calculator

The reconstitution calculator allows you to quickly calculate the volume of a reagent to reconstitute your vial. Simply enter the mass of reagent and the target concentration and the calculator will determine the rest.

Volume (to add to vial)

Mass (in vial)

Desired Reconstitution Concentration

Background: BPIFB1

BPIFB1 (BPI fold-containing family B member 1), also named LPLUNC1, is a member of the BPI-fold (BPIF) containing/Plunc (palate, lung, and nasal epithelium clone) superfamily of putative innate defense molecules which are predominantly expressed in regions of the oral cavity, nasopharynx and upper respiratory tract (1, 2). BPIF proteins exist as two subgroups, BPIFA (formally SPLUNCs) and BPIFB (formally LPLUNCs) (1, 3). BPIFA proteins have structural homology to the N-terminal domain of BPI whereas BPIFB proteins have structural homology to both domains of BPI (2). Human BPIFB1 cDNA encodes a 484 amino acid (aa) precursor protein with a putative 21 aa signal peptide and a 463 aa mature chain. The mature human BPIFB1 shares approximately 57% and 56% aa sequence identity with mouse and rat BPIFB1, respectively. BPIF proteins appear to exhibit distinct tissue and cell specific expression patterns with various family members, being localized to a number of glandular structures within the upper respiratory tract, nasopharyngeal regions and oral cavity where they are secreted from these tissues and are found in high levels in saliva and nasal and respiratory lining fluids (2). BPIFB1 plays a role in diverse functions, including neutralizing endotoxin (LPS) in septic shock patients, inhibition of endothelial cell growth, dendritic cell maturation, as an anti-angiogenic, chemoattractant or opsonization agent (2). Although less characterized as BPIFA1, BPIFB1 may also function as an innate immune molecule sensing and responding to Gram-negative bacteria (4). BPIFA1 and BPIFB1 expression was increased in late stage chronic obstructive pulmonary disease (COPD) patients, and elevated levels correlate with disease severity (5). BPIFB1 is also upregulated in cystic fibrosis (CF) lung disease and may play a role in the pathogenesis of the disease (6).

Item	Value
References	Bingle, C. D. and C. J. Craven (2002) Hum. Mol. Genet. 11:937. Alves, D. B. et al. (2017) Braz. Oral Res. 31:e6. Bingle, L. et al. (2012) Histochem. Cell Biol. 138:749. Balakrishnan, A. et al. (2013) Innate Immun. 19:339. De Smet, E. G. et al. (2017) Int. J. Chron. Obstruct. Pulmon. Dis. 13:11. Saferali, A. et al. (2015) Am. J. Respir. Cell. Mol. Biol. 53:607.
Long Name	BPI Fold Containing Family B Member 1
Entrez Gene IDs	92747 (Human); 228801 (Mouse); 499926 (Rat)
Alternate Names	BPIFB1, C20orf114, LPLUNC1, MGC14597, VEMSGP, Von Ebner minor salivary gland protein, bA49G10.6, chromosome 20 open reading frame 114, dJ1187J4.1, long palate, lung and nasal epithelium carcinoma associated 1, long palate, lung and nasal epithelium carcinoma-associated protein 1

Citations for Recombinant Human BPIFB1 His-tag Protein, CF

View all citations for the Proteins and Enzymes platform.
Please visit our Instrument Citation Database to search our collection of scientific articles that feature our instruments.

Recombinant Human BPIFB1 His-tag Protein, CF

Order Information

Shipping Information

Key Product Details

Complete Your Research

Product Specifications